Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cellular Biomedicine Group, Inc.CBMG · Entity 142413 | Director | February 19, 2021 | February 19, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cellular Biomedicine Group, Inc.
Report date February 19, 2021 · Filed February 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $14.93 · Expires 2029-10-12 | Direct | 0 |
Reported balance
After 2021-02-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-02-19 · Disposition to issuer · Disposed 5,044 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 11, 2020, by and among Cellular Biomedicine Group, Inc. (the "Company"), CBMG Holdings ("Parent") and CBMG Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Parent (the "Merger"). The Merger became effective on February 19, 2021 (the "Closing Date"). Pursuant to the Merger Agreement, at the effective time of the Merger, each stock option was cancelled and exchanged for the right to receive an amount in cash equal to (A) the total number of shares of common stock subject to such stock option multiplied by (B) the excess, if any, of the per share merger consideration of $19.75 over the exercise price of the stock option. |
| Non-Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $14.68 · Expires 2030-04-25 | Direct | 0 |
Reported balance
After 2021-02-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-02-19 · Disposition to issuer · Disposed 4,983 · Balance 0 F2: The exercise price of this option to purchase shares of common stock was previously reported erroneously as $14.65 in the Reporting Person's Form 4 filed on April 28, 2020. F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 11, 2020, by and among Cellular Biomedicine Group, Inc. (the "Company"), CBMG Holdings ("Parent") and CBMG Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Parent (the "Merger"). The Merger became effective on February 19, 2021 (the "Closing Date"). Pursuant to the Merger Agreement, at the effective time of the Merger, each stock option was cancelled and exchanged for the right to receive an amount in cash equal to (A) the total number of shares of common stock subject to such stock option multiplied by (B) the excess, if any, of the per share merger consideration of $19.75 over the exercise price of the stock option. F3: In connection with the Merger, unvested options were accelerated and vested in full at the effective time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 11, 2020, by and among Cellular Biomedicine Group, Inc. (the "Company"), CBMG Holdings ("Parent") and CBMG Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Parent (the "Merger"). The Merger became effective on February 19, 2021 (the "Closing Date"). Pursuant to the Merger Agreement, at the effective time of the Merger, each stock option was cancelled and exchanged for the right to receive an amount in cash equal to (A) the total number of shares of common stock subject to such stock option multiplied by (B) the excess, if any, of the per share merger consideration of $19.75 over the exercise price of the stock option.
F2: The exercise price of this option to purchase shares of common stock was previously reported erroneously as $14.65 in the Reporting Person's Form 4 filed on April 28, 2020.
F3: In connection with the Merger, unvested options were accelerated and vested in full at the effective time of the Merger.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BION ENVIRONMENTAL TECHNOLOGIES INC
Report date January 16, 2025 · Filed January 28, 2025
Section 16 reporting ended · disclosed 2025-01-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Adjusted 2015 Convertble NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.12 | Direct | 0 |
Reported balance
After 2025-01-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-16 · Other · Disposed Not disclosed · Balance 0 F4: As of 1/16/2025, Mr. Schafer owns 1,215,000 options to purchase common stock with exercise prices ranging from $.60 to $1.20 and expiration dates ranging from 12/31/2025 to 12/31/2026. These options carry the potential price adjustment of 75%. F2: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. |
| Common StockSEC Table I · non-derivative | Direct | 158,254 |
Reported balance
Holding disclosure · report date 2025-01-16 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 158,254 F1: As of 1/16/2025 Mr. Schafer owns 158,254 shares of Common Stock. Effective 12/31/2024, Mr. Schafer retired from the Board of Directors of Bion Environmental Technologies, Inc.. This will be the final filing for Mr. Schafer. |
| Adjust 2020 Convertible ObligationSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-16 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F3: As of 1/16/2025, Mr. Schafer is the owner of the Adjusted 2020 Convertible Note. The balance of the note is $101,973.02 and is convertible at $.0953 into 1,070,021 shares and 535,011 warrants. The maturity date of this note is 4/15/25. |
| Options Right to buySEC Table II · derivative / convertible security | Direct | 1,215,000 |
Reported balance
Holding disclosure · report date 2025-01-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 1,215,000 F4: As of 1/16/2025, Mr. Schafer owns 1,215,000 options to purchase common stock with exercise prices ranging from $.60 to $1.20 and expiration dates ranging from 12/31/2025 to 12/31/2026. These options carry the potential price adjustment of 75%. |
| Class Coverage WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 | Direct | 23,934 |
Reported balance
Holding disclosure · report date 2025-01-16 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,934 F5: As of 1/16/2025, Mr. Schafer owns 23,934 warrants with an exercise price of $.75 until 12/31/2026. These warrants carry a potential price adjustment of 75%. |
Filing footnotes · ownership attribution and instrument terms
F1: As of 1/16/2025 Mr. Schafer owns 158,254 shares of Common Stock. Effective 12/31/2024, Mr. Schafer retired from the Board of Directors of Bion Environmental Technologies, Inc.. This will be the final filing for Mr. Schafer.
F2: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note.
F3: As of 1/16/2025, Mr. Schafer is the owner of the Adjusted 2020 Convertible Note. The balance of the note is $101,973.02 and is convertible at $.0953 into 1,070,021 shares and 535,011 warrants. The maturity date of this note is 4/15/25.
F4: As of 1/16/2025, Mr. Schafer owns 1,215,000 options to purchase common stock with exercise prices ranging from $.60 to $1.20 and expiration dates ranging from 12/31/2025 to 12/31/2026. These options carry the potential price adjustment of 75%.
F5: As of 1/16/2025, Mr. Schafer owns 23,934 warrants with an exercise price of $.75 until 12/31/2026. These warrants carry a potential price adjustment of 75%.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2025 Filed Jan 28, 2025 16:01 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | OtherAdjusted 2015 Convertble Note · Derivative | Not disclosed | $0.00 Strike: $0.12 | $4,245.48 |
DisclosureSEC source: 0001079973-25-000150 · ownership.xml · derivative · entry 2 Schafer Edward T · CIK 0001376093 · Former Board member-12/31/24 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: See footnote · 0 shares Expires not disclosed F4 · kind: As of 1/16/2025, Mr. Schafer owns 1,215,000 options to purchase common stock with exercise prices ranging from $.60 to $1.20 and expiration dates ranging from 12/31/2025 to 12/31/2026. These options carry the potential price adjustment of 75%. F2 · reported_value: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. F2 · derivative.exercise_date: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. F2 · derivative.expiration_date: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. F2 · derivative.underlying: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. F2 · derivative.underlying_shares: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. F2 · balance_after: Effective 1/16/2025, Mr. Schafer voluntarily surrendered 36,918 shares that would have been issued as the result of the conversion of $4,245.48 of the Adjusted 2015 Convertible Note. Read SEC document |
| February 01, 2023 Filed Feb 28, 2023 02:47 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantAdjusted 2015 Convertble Note · Derivative | Not disclosed | $0.00 Strike: $0.12 | $4,245.47 |
DisclosureSEC source: 0001079973-23-000266 · ownership.xml · derivative · entry 4 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: See footnote · Not disclosed shares Expires not disclosed F4 · kind: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. F4 · reported_value: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. F4 · derivative.exercise_date: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. F4 · derivative.expiration_date: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. F4 · derivative.underlying: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. F4 · underlyingValue: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. F4 · valueOwnedAfter: The note balance 'Adjusted 2015 Convertible Note' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.115 replacing the prior conversion terms of $.60 per share that will yield equity slightly less than the unadjusted 2015 Convertible Note would have received if converted on the maturity date. The balance of the Adjusted 2015 Convertible Note is $4,245.47 and is convertible into 36,918 BNET restricted shares of common stock. Read SEC document |
| February 01, 2023 Filed Feb 28, 2023 02:47 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | Disposition to issuer2015 Convertible Note · Derivative | Not disclosed | $0.00 Strike: $0.60 | $21,227.37 |
DisclosureSEC source: 0001079973-23-000266 · ownership.xml · derivative · entry 3 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: See footntoe · Not disclosed shares Expires not disclosed F3 · kind: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. F3 · reported_value: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. F3 · derivative.exercise_date: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. F3 · derivative.expiration_date: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. F3 · derivative.underlying: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. F3 · underlyingValue: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. F3 · valueOwnedAfter: On February 1, 2023, the principal of most of the 2015 Convertible Note of $21,277.37 was adjusted down by 80 %. At the end of the maturity date of July 1, 2024, the balance of the unadjusted 2015 Convertible Note would be $22,155.68 and convertible @ $.60 into 36,927 BNET restricted shares of common stock. Read SEC document |
| February 01, 2023 Filed Feb 28, 2023 02:47 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantAdjust 2020 Convertible Obligation · Derivative | Not disclosed | $0.00 Strike: $0.10 | $101,973.01 |
DisclosureSEC source: 0001079973-23-000266 · ownership.xml · derivative · entry 2 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: See footnote · Not disclosed shares Expires not disclosed F2 · kind: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F2 · reported_value: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F2 · derivative.exercise_date: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F2 · derivative.expiration_date: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F2 · derivative.underlying: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F2 · underlyingValue: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F2 · valueOwnedAfter: The principal note balance 'Adjusted 2020 Convertible Obligation' will not accrue interest until the maturity date of July 1, 2024, with conversion terms of $.0953 replacing the prior conversion terms of $.50. This change will yield equity slightly less than the unadjusted 2020 Convertible Obligation would have received if converted on the maturity date. The balance of the Adjusted 2020 Convertible Obligation is $101,973.01 and is convertible into 1,070,021 units of BNET restricted securities consisting of 1,070,021 shares and 535,011 warrants @$.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. Read SEC document |
| February 01, 2023 Filed Feb 28, 2023 02:47 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | Disposition to issuer2020 Convertible Obligation · Derivative | Not disclosed | $0.00 Strike: $0.50 | $509,865.07 |
DisclosureSEC source: 0001079973-23-000266 · ownership.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: See footnote · Not disclosed shares Expires not disclosed F1 · kind: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F1 · reported_value: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F1 · derivative.exercise_date: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F1 · derivative.expiration_date: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F1 · derivative.underlying: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F1 · underlyingValue: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. F1 · valueOwnedAfter: On February 1, 2023, the principal of most of the 2020 Convertible Obligation of $509,865.07 was adjusted down by 80%. At the end of the maturity date of July 1, 2024, the balance of the 2020 Convertible Obligation would be $535,585.27 and would be convertible into 1,071,171 units of BNET restricted securities consisting of 1,071,171 shares and 535,586 warrants @ $.75 each exercisable through three years after the conversion date. Each of these warrants carry an exercise bonus of 75%. Read SEC document |
| April 29, 2022 Filed May 5, 2022 17:24 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantOptions (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001079973-22-000543 · ownership.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2025-12-31 F1 · security: Each of these options carry an exercise bonus of 75% until 12/31/2025. Read SEC document |
| March 02, 2021 Filed Apr 5, 2021 22:14 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001079973-21-000236 · ownership.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-12-31 F1 · security: DB 2020 Convertible Obligation ('Note') Read SEC document |
| February 19, 2021 Filed Feb 19, 2021 15:13 UTC | Cellular Biomedicine Group, Inc. CBMG · Entity 142413 | Disposition to issuerNon-Qualified Stock Option · Derivative | 4,983 | Not disclosed Strike: $14.68 | Not disclosed |
DisclosureSEC source: 0001654954-21-001902 · section16.xml · derivative · entry 2 Schafer Edward T · CIK 0001376093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,983 shares Expires 2030-04-25 F2 · derivative.exercise_price: The exercise price of this option to purchase shares of common stock was previously reported erroneously as $14.65 in the Reporting Person's Form 4 filed on April 28, 2020. F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 11, 2020, by and among Cellular Biomedicine Group, Inc. (the "Company"), CBMG Holdings ("Parent") and CBMG Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Parent (the "Merger"). The Merger became effective on February 19, 2021 (the "Closing Date"). Pursuant to the Merger Agreement, at the effective time of the Merger, each stock option was cancelled and exchanged for the right to receive an amount in cash equal to (A) the total number of shares of common stock subject to such stock option multiplied by (B) the excess, if any, of the per share merger consideration of $19.75 over the exercise price of the stock option. F3 · derivative.exercise_date: In connection with the Merger, unvested options were accelerated and vested in full at the effective time of the Merger. Read SEC document |
| February 19, 2021 Filed Feb 19, 2021 15:13 UTC | Cellular Biomedicine Group, Inc. CBMG · Entity 142413 | Disposition to issuerNon-Qualified Stock Option · Derivative | 5,044 | Not disclosed Strike: $14.93 | Not disclosed |
DisclosureSEC source: 0001654954-21-001902 · section16.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,044 shares Expires 2029-10-12 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 11, 2020, by and among Cellular Biomedicine Group, Inc. (the "Company"), CBMG Holdings ("Parent") and CBMG Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Parent (the "Merger"). The Merger became effective on February 19, 2021 (the "Closing Date"). Pursuant to the Merger Agreement, at the effective time of the Merger, each stock option was cancelled and exchanged for the right to receive an amount in cash equal to (A) the total number of shares of common stock subject to such stock option multiplied by (B) the excess, if any, of the per share merger consideration of $19.75 over the exercise price of the stock option. Read SEC document |
| May 04, 2020 Filed May 6, 2020 16:16 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantOptions (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001079973-20-000348 · ownership.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2024-12-31 F1 · security: Each of these options carry a potential exercise bonus of 50 percent. Read SEC document |
| April 25, 2020 Filed Apr 28, 2020 16:24 UTC | Cellular Biomedicine Group, Inc. CBMG · Entity 142413 | GrantNon-qualified stock option (right to buy) · Derivative | 4,983 | $0.00 Strike: $14.65 | $0.00 |
DisclosureSEC source: 0001654954-20-004552 · section16.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,983 Underlying: Common Stock · 4,983 shares Expires 2023-04-25 F1 · derivative.exercise_date: This option becomes exercisable and fully vests on April 23, 2021. Read SEC document |
| October 12, 2019 Filed Oct 15, 2019 16:12 UTC | Cellular Biomedicine Group, Inc. CBMG · Entity 142413 | GrantNon-qualified stock option · Derivative | 5,044 | $0.00 Strike: $14.93 | $0.00 |
DisclosureSEC source: 0001654954-19-011772 · section16.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 Underlying: Common stock · 5,044 shares Expires 2029-04-24 Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 21:13 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantOptions (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001079973-19-000431 · ownership.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2023-12-31 F1 · security: Each of which options includes a potential future 50% exercise bonus Read SEC document |
| November 30, 2017 Filed Dec 22, 2017 22:19 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | OtherJanuary 2015 Convertible Note · Derivative | 211,334 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001140361-17-047228 · doc1.xml · derivative · entry 5 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,270 Underlying: Warrants · 421,270 shares Expires not disclosed F3 · security: The number of warrants included in Units to be received in conversion of existing "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has increased from 1/4 to 1/2 per Unit which change increased potential warrants to be received in the event of conversion of Mr. Schafer's "January 2015 Convertible Note" by 210,635 at November 7, 2017 including interest accruals through November 30, 2017 (with future increase due to subsequent interest accruals). The Potential future "exercise bonus" for these warrants (and all other options and warrants owned by Mr. Schafer (and his donees)/assignees) was increased to 75% from 50%. See Notes 7, 9 & 10 Financial Statements Form 10Q for quarter ended 9/30/17. F4 · price: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. F2 · derivative.exercise_date: This report reflects the cancellation (effective November 7, 2017) (per agreements reached between October 14 - Nov 6, 2017) of $121,386 of accrued convertible deferred compensation (including November 2017 accrual) which was convertible into 144,507 shares of common stock at November 7, 2017 (see Notes 5&10 Financial Statements Form 10-Q for quarter ended 9/30/17 (Note that, per item 12, Form 10 - k (for year ended June 30 2017) $120,269 of convertible deferred compensation was convertible into 133,164 shares at August 15, 2017. This category of security's amount has varied with the addition of accrued deferred compensation and has fluctuated in number as the market-based conversion price has varied by formula. New accruals will commence during December 2017 with the same variables in place. F4 · derivative.expiration_date: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. Read SEC document |
| November 30, 2017 Filed Dec 22, 2017 22:19 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | OtherJanuary 2015 Convertible Note · Derivative | 2,798 | Not disclosed Strike: $0.50 | Not disclosed |
DisclosureSEC source: 0001140361-17-047228 · doc1.xml · derivative · entry 4 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 835,852 Underlying: Common Stock · 842,540 shares Expires not disclosed F4 · price: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. F2 · derivative.exercise_date: This report reflects the cancellation (effective November 7, 2017) (per agreements reached between October 14 - Nov 6, 2017) of $121,386 of accrued convertible deferred compensation (including November 2017 accrual) which was convertible into 144,507 shares of common stock at November 7, 2017 (see Notes 5&10 Financial Statements Form 10-Q for quarter ended 9/30/17 (Note that, per item 12, Form 10 - k (for year ended June 30 2017) $120,269 of convertible deferred compensation was convertible into 133,164 shares at August 15, 2017. This category of security's amount has varied with the addition of accrued deferred compensation and has fluctuated in number as the market-based conversion price has varied by formula. New accruals will commence during December 2017 with the same variables in place. F4 · derivative.expiration_date: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. Read SEC document |
| November 07, 2017 Filed Dec 22, 2017 22:19 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantJanuary 2015 Convertible Note Warrants · Derivative | 210,635 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-047228 · doc1.xml · derivative · entry 3 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,270 Underlying: Common Stock · 421,270 shares Expires not disclosed F4 · price: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. F4 · derivative.exercise_date: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. F4 · derivative.expiration_date: Outstanding "January 2015 Convertible Note" (as defined in Form 10-Q Financial Statements, Note 7 and other SEC filings) has a balance (principal plus accrued interest) of approximately $421,270 as of November 30, 2017. The note is convertible at $.50 per unit into units consisting of 1 share of common stock and 1/2 warrant ((842,540 Units consisting of 842,540 shares of common stock and 421,270 warrants, in aggregate). See Note 3 above. (See Notes 7, 9 & 10 Financial Statements, Form 10 - Q for quarter ended 9/30/17. The number of Units will increase as interest accrues. Read SEC document |
| November 07, 2017 Filed Dec 22, 2017 22:19 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | OtherConvertible Deferred Compensation · Derivative | 144,507 | Not disclosed Strike: $0.72 | Not disclosed |
DisclosureSEC source: 0001140361-17-047228 · doc1.xml · derivative · entry 2 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,507 shares Expires not disclosed F2 · price: This report reflects the cancellation (effective November 7, 2017) (per agreements reached between October 14 - Nov 6, 2017) of $121,386 of accrued convertible deferred compensation (including November 2017 accrual) which was convertible into 144,507 shares of common stock at November 7, 2017 (see Notes 5&10 Financial Statements Form 10-Q for quarter ended 9/30/17 (Note that, per item 12, Form 10 - k (for year ended June 30 2017) $120,269 of convertible deferred compensation was convertible into 133,164 shares at August 15, 2017. This category of security's amount has varied with the addition of accrued deferred compensation and has fluctuated in number as the market-based conversion price has varied by formula. New accruals will commence during December 2017 with the same variables in place. F2 · derivative.exercise_date: This report reflects the cancellation (effective November 7, 2017) (per agreements reached between October 14 - Nov 6, 2017) of $121,386 of accrued convertible deferred compensation (including November 2017 accrual) which was convertible into 144,507 shares of common stock at November 7, 2017 (see Notes 5&10 Financial Statements Form 10-Q for quarter ended 9/30/17 (Note that, per item 12, Form 10 - k (for year ended June 30 2017) $120,269 of convertible deferred compensation was convertible into 133,164 shares at August 15, 2017. This category of security's amount has varied with the addition of accrued deferred compensation and has fluctuated in number as the market-based conversion price has varied by formula. New accruals will commence during December 2017 with the same variables in place. F2 · derivative.expiration_date: This report reflects the cancellation (effective November 7, 2017) (per agreements reached between October 14 - Nov 6, 2017) of $121,386 of accrued convertible deferred compensation (including November 2017 accrual) which was convertible into 144,507 shares of common stock at November 7, 2017 (see Notes 5&10 Financial Statements Form 10-Q for quarter ended 9/30/17 (Note that, per item 12, Form 10 - k (for year ended June 30 2017) $120,269 of convertible deferred compensation was convertible into 133,164 shares at August 15, 2017. This category of security's amount has varied with the addition of accrued deferred compensation and has fluctuated in number as the market-based conversion price has varied by formula. New accruals will commence during December 2017 with the same variables in place. Read SEC document |
| November 07, 2017 Filed Dec 22, 2017 22:19 UTC | BION ENVIRONMENTAL TECHNOLOGIES INC BNET · Entity 8007 | GrantOptions (Right to Buy) · Derivative | 190,000 | $0.05 Strike: $0.75 | $9,500.00 |
DisclosureSEC source: 0001140361-17-047228 · doc1.xml · derivative · entry 1 Schafer Edward T · CIK 0001376093 · Director · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2020-12-31 F1 · security: Each of which options includes a potential future 90% exercise bonus "exercise bonus" (See Notes 9&10, Financial Statements, Form 10-Q for quarter ended 9/30/17 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.